Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 31 Mar ‘24 |
|
|---|---|---|---|---|---|
| $63.7M | $66.2M | $2.47M | 70.2% |
|
|
| $63.6M | $80.2M | $16.7M | 21.4% |
|
|
| $63.1M | $231M | $168M | 12.8% |
|
|
329
Iovance Biotherapeutics
IOVA
$774M
| $62.4M | $93.8M | $31.4M | 85.6% |
|
| $61.6M | $110M | $48.1M | 41.7% |
|
|
| $61.5M | $153M | $91.5M | 565% |
|
|
| $61.4M | $63.2M | $1.83M | 33.2% |
|
|
| $61.2M | $80.3M | $19.1M | 3.29% |
|
|
| $61.1M | $1.21B | $1.14B | 15.6% |
|
|
| $61M | $291M | $230M | 2.67% |
|
|
336
Annaly Capital Management
NLY
$13.2B
| $60.8M | $138M | $76.9M | 5.64% |
|
| $60.7M | $118M | $56.8M | 8.53% |
|
|
| $60.6M | $103M | $42M | 7.59% |
|
|
| $60.5M | $102M | $41.7M | 13.7% |
|
|
| $59.9M | $62.9M | $3.02M | 44.5% |
|
|
| $59.7M | $643M | $584M | 20.5% |
|
|
| $59.4M | $140M | $80.5M | 19.7% |
|
|
| $59.3M | $141M | $81.5M | 71.8% |
|
|
| $58.5M | $586M | $527M | 80.8% |
|
|
| $58.3M | $164M | $106M | 7.33% |
|
|
| $58.3M | $458M | $399M | 58.6% |
|
|
| $58M | $147M | $88.9M | 9.89% |
|
|
| $57.6M | $179M | $121M | 6.03% |
|
|
| $57.5M | $88.3M | $30.9M | 9.47% |
|
|
| $57.4M | $219M | $161M | 30.2% |
|